These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 16267366)

  • 21. The role of oxidative stress in chronic obstructive pulmonary disease.
    Bowler RP; Barnes PJ; Crapo JD
    COPD; 2004; 1(2):255-77. PubMed ID: 17136992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of airway mucus hypersecretion.
    Rogers DF; Barnes PJ
    Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of oxidative stress in the pathogenesis of COPD.
    Nucera F; Mumby S; Paudel KR; Dharwal V; DI Stefano A; Casolaro V; Hansbro PM; Adcock IM; Caramori G
    Minerva Med; 2022 Jun; 113(3):370-404. PubMed ID: 35142479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease.
    Macnee W; Rahman I
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 2):S58-65. PubMed ID: 10556172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Novel therapeutics for COPD].
    Hoshino Y; Muro S; Mishima M
    Nihon Rinsho; 2011 Oct; 69(10):1826-30. PubMed ID: 22073581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathogenesis of the chronic obstructive pulmonary disease (COPD)].
    Musil J
    Vnitr Lek; 2004 Sep; 50(9):663-7. PubMed ID: 15580897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.
    Lin JL; Thomas PS
    COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging drugs for chronic obstructive pulmonary disease.
    Matera MG; Calzetta L; Segreti A; Cazzola M
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):61-82. PubMed ID: 22335427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema.
    Demedts IK; Demoor T; Bracke KR; Joos GF; Brusselle GG
    Respir Res; 2006 Mar; 7(1):53. PubMed ID: 16571143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospects for new drugs for chronic obstructive pulmonary disease.
    Barnes PJ; Hansel TT
    Lancet; 2004 Sep 11-17; 364(9438):985-96. PubMed ID: 15364192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory mediators in chronic obstructive pulmonary disease.
    Chung KF
    Curr Drug Targets Inflamm Allergy; 2005 Dec; 4(6):619-25. PubMed ID: 17305518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statins in the treatment of COPD and asthma-where do we stand?
    So JY; Dhungana S; Beros JJ; Criner GJ
    Curr Opin Pharmacol; 2018 Jun; 40():26-33. PubMed ID: 29334676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New anti-inflammatory targets for chronic obstructive pulmonary disease.
    Barnes PJ
    Nat Rev Drug Discov; 2013 Jul; 12(7):543-59. PubMed ID: 23977698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.
    Rahman I; Kinnula VL
    Expert Rev Clin Pharmacol; 2012 May; 5(3):293-309. PubMed ID: 22697592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fluimucyl-antibiotic IT: ability of antioxidant therapy for patients with acute attack of infectious chronic obstructive lung disease].
    Vysotiuk L; Hromova A
    Lik Sprava; 2006; (1-2):65-81. PubMed ID: 16689098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effects of Resveratrol on Inflammation and Oxidative Stress in a Rat Model of Chronic Obstructive Pulmonary Disease.
    Wang XL; Li T; Li JH; Miao SY; Xiao XZ
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28895883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytokines and proteases involved in pathogenesis of COPD].
    Yamaya A; Osanai K
    Nihon Rinsho; 2011 Oct; 69(10):1748-53. PubMed ID: 22073567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Balance of proteinases and antiproteinases and smoking tobacco].
    Kołodziejczyk J; Wojciechowska M; Bartuzi Z; Dziedziczko A
    Pneumonol Alergol Pol; 2011; 79(3):207-14. PubMed ID: 21509733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Future directions in the pharmacologic therapy of chronic obstructive pulmonary disease.
    Buhl R; Farmer SG
    Proc Am Thorac Soc; 2005; 2(1):83-93. PubMed ID: 16113474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.